Ahmadzay et al. Real world secukinumab in PsA data in 1202 patients. Smokers/ex-smokers have 30% lower treatment retenti

Social Author Image

https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg

Tweet Author

Social Author Name

Richard Conway

Tweet Content

Ahmadzay et al. Real world secukinumab in PsA data in 1202 patients. Smokers/ex-smokers have 30% lower treatment retention. But if they maintain treatment, appear to respond equally well. BMI no effect. @RheumNow #ACR24 Abstr#2350 https://t.co/XVPmEBbRu8 https://t.co/QyJirWRKvq

Links

Do Smoking and Obesity Impact Secukinumab Treatment Outcomes? Real-world Data f… https://acrabstracts.org/abstract/do-smoking-and-obesity-impact-secukinumab-tre…

https://x.com/RichardPAConway/status/1858553252964692082/photo/1

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

Ahmadzay et al. Real world secukinumab in PsA data in 1202 patients. Smokers/ex-smokers have 30% lower treatment retenti

Do you get our email newsletter?